Diamantis I Tsilimigras, Yutaka Endo, Francesca Ratti, Hugo P Marques, François Cauchy, Vincent Lam, George A Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Minoru Kitago, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Ana Gleisner, Feng Shen, Itaru Endo, Timothy M Pawlik
BACKGROUND: The aMAP score is a proposed model to predict the development of hepatocellular carcinoma (HCC) among high-risk patients with chronic hepatitis. The role of the aMAP score to predict long-term survival among patients following resection of HCC has not been determined. METHODS: Patients undergoing resection for HCC between 2000 and 2020 were identified using a multi-institutional database. The impact of the aMAP score on long-term outcomes following HCC resection was assessed...
April 2024: HPB: the Official Journal of the International Hepato Pancreato Biliary Association